Prot #RPC01-3102: A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

Project: Research project

Project Details

StatusActive
Effective start/end date11/2/1611/2/22

Funding

  • Quintiles, Inc. (Prot #RPC01-3102)
  • Celgene International II Sàrl (Prot #RPC01-3102)